not tagged
not tagged
#ims2022 | fantastic presentation by on #qol after #cartcell infusion. with both approved agents, there was an initial drop at the same time of higher symptom burden, and a progressive improvement after, reaching baseline status, although that was still poor #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma